Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.
about
Pleiotropic effects of statins in the diseases of the liverNon invasive tools for the diagnosis of liver cirrhosis.The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.von Willebrand Factor Propeptide: A Potential Disease Biomarker Not Affected by ABO Blood Groups.Von Willebrand factor and alkaline phosphatase predict re-transplantation-free survival after the first liver transplantation.Advances in the treatment of portal hypertension in cirrhosis.A conceptual and practical approach to haemostasis in paediatric liver disease.VAP score as a novel non-invasive liver fibrosis model in patients with chronic hepatitis C.Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure.Complement 5a is an indicator of significant fibrosis and earlier cirrhosis in patients chronically infected with hepatitis B virus.Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis.Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression.Von Willebrand factor deficiency reduces liver fibrosis in mice.Intrahepatic angiogenesis increases portal hypertension in hepatitis B patients with cirrhosis.von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.
P2860
Q26741176-593D6D7C-42CF-4BA0-89AA-D46CDB7EF660Q30421450-91B76E3A-3F6D-4DA1-B62A-BA9E04F2748EQ35928746-E36B0911-7BEB-4085-8399-DD80EF5D1743Q35994251-E1C22CFC-1C98-431F-A947-3406CFCF3103Q37741829-6D572EB0-2228-4735-B342-F21939D6599CQ38776991-EC5C594F-9A18-4F21-BBAA-5F1FC784716BQ38788396-59B2DAC9-365F-4542-B25D-F7FD487EE111Q38863591-7821F97E-BD8D-45A1-BD52-59CDC2C15D2EQ39206078-5FECF5A6-A22C-4A5F-A7D8-839147B18462Q40548408-6BB1F519-6DA8-40E6-BF26-6AB672CCA811Q42202312-DB6AC5B9-174F-44B9-8294-DA9A43F12D82Q47122280-28545596-3704-4B35-B60B-B5702FFA67EBQ50206717-FDF7583B-32FD-4F70-BCD0-6D731230B5FBQ50242973-732CE8FD-22CD-4063-9F69-E1C2DEC6B7D4Q53543540-CE596ADD-D306-4869-804C-E2D026878C32
P2860
Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Von Willebrand Factor as a new ...... ents with chronic hepatitis C.
@en
Von Willebrand Factor as a new ...... ents with chronic hepatitis C.
@nl
type
label
Von Willebrand Factor as a new ...... ents with chronic hepatitis C.
@en
Von Willebrand Factor as a new ...... ents with chronic hepatitis C.
@nl
prefLabel
Von Willebrand Factor as a new ...... ents with chronic hepatitis C.
@en
Von Willebrand Factor as a new ...... ents with chronic hepatitis C.
@nl
P2093
P2860
P356
P1476
Von Willebrand Factor as a new ...... ents with chronic hepatitis C.
@en
P2093
M Ferlitsch
M Peck-Radosavljevic
S Hametner
P2860
P304
P356
10.1111/APT.12564
P407
P577
2013-12-05T00:00:00Z